Additionally, metformin can reduce the protein stability of SLC7A11 in breast cancer cells by inhibiting its UFMylation, leading to increased intracellular Fe2+ and lipid ROS levels, thereby inducing ferroptosis (Yang et al., 2021a). Here, SLC7A11 is linked to breast carcinoma.